NASDAQ •
Healthcare •
Biotechnology •
Quote as of 05/13/2026 14:25
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization5.54 mln
Float0.64 mln
Earnings Date04/01/2026
Piotroski F-Score
2
/ 9
Weak
Relative Strength
2
/ 100
Severely lagging
Debt / Equity
-0.53
Negative equity
ROE
-32,523
Deeply negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Artelo Biosciences is a US-based clinical-stage drug development company focused on treatments that work through the body's lipid-signaling systems. Its pipeline includes three candidates targeting conditions such as cancer-related appetite loss, nerve pain, anxiety, depression, PTSD, and epilepsy. Founded in 2011 and headquartered in Solana Beach, California, the company operates under a name it adopted in 2017.
